Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
| Autor: | Reddy, B.K.M., Lokesh, V., Vidyasagar, M.S., Shenoy, K., Babu, K.G., Shenoy, A., Naveen, T., Joseph, Bindhu, Bonanthaya, R., Nanjundappa, Bapsy, P.P., Loknatha, Shetty, Jayarama, Prasad, Krishna, Tanvir Pasha, C.R. |
|---|---|
| Zdroj: | In Oral Oncology May 2014 50(5):498-505 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect